Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

2 articles from the last 30 days matching "Idiopathic Pulmonary Fibrosis"

🔴 BreakingDrug approvalEMAYesterday

New medicine for two types of pulmonary fibrosis

The European Medicines Agency has approved a new medicine called Jascayd (nerandomilast) to treat adults with two types of lung scarring diseases: idiopathic pulmonary fibrosis and progressive fibrosing interstitial lung disease. This approval means the medicine is now available for patients in the European Union. This is the first time this particular medicine has been approved for these conditions in Europe.

WHY IT MATTERSPatients with idiopathic pulmonary fibrosis in the EU now have access to a newly approved treatment option that may help slow lung scarring and preserve breathing ability.
💬 Ask your doctoridiopathic pulmonary fibrosisprogressive fibrosing interstitial lung disease
ResearchBIORXIV5 days ago

Preprint: Polygenic risk scores enhance the identification of carriers of monogenic forms of idiopathic pulmonary fibrosis

Scientists found that a new scoring system called a polygenic risk score (PRS) could help doctors identify which patients with idiopathic pulmonary fibrosis (IPF)—a serious lung disease where lung tissue becomes scarred—are more likely to carry rare genetic mutations. The study suggests that patients with lower PRS scores may be better candidates for genetic testing to find these rare mutations, which could improve how doctors diagnose and understand the disease.

WHY IT MATTERSIf validated, this approach could help IPF patients get faster genetic diagnoses by identifying who should be prioritized for rare variant testing, potentially leading to earlier intervention and more personalized treatment strategies.
ℹ Good to knowidiopathic pulmonary fibrosis

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases